Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

bio Genous

bio Genous provides biomedical scientific research and drug development services.
2022
51-100
Hangzhou, Zhejiang, China

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

13.08M

Last Funding Date

31-12-2024

Startup Stage

Early Stage

Lead Investors

Marathon Venture Partners, CMG-SDIC Capital Management, AstraZeneca CICC Medical Industry Fund

Something missing or incorrect on this page? Help us enrich this information